SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

07 Nov 2023 Evaluate
The sales slipped to Rs. 3561.40 millions for the September 2023 quarter as against Rs. 4045.00 millions during the year-ago period.Net profit declined -8.97% to Rs. 418.10 millions from Rs. 459.30 millions.The Operating Profit of the company witnessed a decrease to 738.00 millions from 815.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 3561.40 4045.00 -11.96 7142.80 7776.50 -8.15 15112.50 9410.20 60.60
Other Income 0.00 12.40 0.00 48.60 12.40 291.94 12.80 25.10 -49.00
PBIDT 738.00 815.00 -9.45 1554.00 1602.10 -3.00 3096.20 1822.90 69.85
Interest 38.20 55.20 -30.80 78.50 95.70 -17.97 204.90 113.40 80.69
PBDT 699.80 759.80 -7.90 1475.50 1506.40 -2.05 2891.30 1709.50 69.13
Depreciation 163.20 145.50 12.16 317.60 269.60 17.80 557.70 372.30 49.80
PBT 536.60 614.30 -12.65 1157.90 1236.80 -6.38 2333.60 1337.20 74.51
TAX 118.50 155.00 -23.55 263.50 305.00 -13.61 616.30 270.00 128.26
Deferred Tax 15.00 22.50 -33.33 50.00 45.00 11.11 95.00 45.00 111.11
PAT 418.10 459.30 -8.97 894.40 931.80 -4.01 1717.30 1067.20 60.92
Equity 453.10 453.10 0.00 453.10 453.10 0.00 453.10 455.60 -0.55
PBIDTM(%) 20.72 20.15 2.85 21.76 20.60 5.60 20.49 19.37 5.76

Aarti Pharmalabs Share Price

696.60 -2.85 (-0.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×